Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 5.64147 | 80 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 6.04598 | 82 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 5.99632 | 82 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 6.29799 | 83 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 6.3083 | 84 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 5.82019 | 83 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 5.62056 | 81 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 5.90967 | 82 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 5.95289 | 82 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 6.17044 | 83 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 6.14803 | 84 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 6.33656 | 84 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 6.4423 | 86 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 6.11805 | 83 |